FC24: Evolving Therapies in the Treatment of Chronic Spontaneous Urticaria: An Online Activity

Section cover
Released on
December 12, 2024
Duration
45 minutes
Earn up to
0.75 AMA PRA Category 1 Credit

Evolving Therapies in the Treatment of Chronic Spontaneous Urticaria: An Online Activity

This activity is supported by educational grants from Genentech, a member of the Roche Group, Novartis Pharmaceuticals Corporation, and Sanofi and Regeneron Pharmaceuticals, Inc.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2025 dermsquared | All Rights Reserved